The University of Kansas Cancer Center (KUCC) was officially awarded National Cancer Institute (NCI) designation on July 12, 2012. The National Cancer Institute had recommended the Cancer Center for the designation earlier in the summer, endorsing a nearly decade-long effort that has brought top cancer researchers, access to advanced care and millions of dollars in cancer research funding to the region and inspired profound advances in the care of cancer patients.
COBRE-PSF Center members participating in this effort include Brian Blagg, Jianwen Fang, Robert Hanzlik, Jennifer Laurence, and Emily Scott.
"The National Cancer Institute has recognized our scientific excellence, and the designation validates what we already knew— that research conducted at The University of Kansas Cancer Center is already helping to eliminate the burden of cancer,"said Roy A. Jensen, M.D., director of The University of Kansas Cancer Center. "We are extremely proud of what this designation means — and it's a dream that could not have become a reality without the commitment and enthusiasm shown by thousands of our closest friends."
As a result of the designation, Jensen said, patients will have access to clinical trials that are available only to NCI-designated cancer centers. The University of Kansas Cancer Center will be able to apply for federal research grants only available to NCI-designated cancer centers, with the potential for bringing millions in additional funding to the area.
Includes excerpts from University of Kansas Medical Center Public Affairs news release